Predictors of first hospitalization due to disease activity and infections in systemic lupus erythematosus patients

Author:

Pons-Estel Guillermo J1,Quintana Rosana1ORCID,Ugarte-Gil Manuel F23ORCID,Harvey Guillermina B4,Wojdyla Daniel4,Serrano-Morales Rosa1ORCID,Gómez Puerta José A5,García Mercedes A6,Catoggio Luis J7,Saurit Verónica8,Drenkard Cristina9ORCID,Da Silva Nilzio A10,Cavalcanti Fernando11,Borba Eduardo12,Sato Emilia13,Neira Oscar14,Massardo Loreto15ORCID,Vásquez Gloria16,Gonzalez Luis Alonso17,Guibert-Toledano Marlene18,Silveira Luis H19,García De La Torre Ignacio20,Sauza del Pozo María Josefina21,Chacón Rosa22,Cardiel Mario H23,Orillion Ashley24,Sbarigia Urbano25,Alemao Evo25,Zazzetti Federico26,Alarcón Graciela S2728ORCID,Pons-Estel Bernardo A1

Affiliation:

1. Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Instituto Cardiovascular de Rosario, Rosario, Argentina

2. Servicio de Reumatología, Hospital Nivel IV Guillermo Almenara Irigoyen, Lima, Peru

3. Grupo Peruano de Estudio de Enfermedades Autoinmunes Sistémicas, Universidad Científica del Sur Facultad de Ciencias de la Salud, Lima, Perú

4. Universidad Nacional de Rosario Facultad de Ciencias Económicas y Estadística, Rosario, Argentina

5. Servicio de Reumatología, Hospital Clinic, Barcelona, Spain

6. Hospital Interzonal General de Agudos General San Martin, La Plata, Argentina

7. Rheumatolgy, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

8. Rheumatology, Hospital Privado Universitario de Cordoba, Cordoba, Argentina

9. Rheumatology, Emory University School of Medicine, Atlanta, GA, USA

10. Reumatología/Departamento de Clínica Médica, Hospital das Clínicas, Universidade Federal de Goiás, Goiania, Brazil

11. Rheumatology/Departamento de Medicina Clínica, Hospital das Clínicas, Universidade Federal de Pernambuco, Goiania, Brazil

12. Rheumatolgy Division, HCFMUSP, Universidade de São Paulo Hospital das Clínicas, Sao Paulo, Brazil

13. Escola Paulista de Medicina, Universidade Federal de São Paulo, Sao Paulo, Brazil

14. Sección de Reumatología, Hospital del Salvador, Universidad de Chile, Santiago de Chile, Chile

15. Universidad San Sebastián Facultad de Medicina, Santiago de Chile, Chile

16. Departamento de Medicina Interna, Universidad de Antioquia, Medellin, Colombia

17. Sección de Reumatología, Departamento de Medicina Interna, Universidad de Antioquia, Medellin, Colombia

18. Centro de Investigaciones Médicas Quirúrgicas, Havana University of Medical Sciences, Havana, Cuba

19. Departamento de Reumatología, Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de Mexico, Mexico

20. Departamento de Inmunología y Reumatología, Hospital General de Occidente de la SS, Universidad de Guadalajara, Guadalajara, Mexico

21. Instituto Mexicano de Seguro Social, Hospital de Especialidades Na 25, IMSS, Ciudad de Mexico, Mexico

22. Servicio de Reumatología, Policlínica Méndez Gimón, Medical Center of Caracas, Caracas, Venezuela

23. Centro de Investigación Clínica de Morelia, Hospital General Dr Miguel Silva, Morelia, Mexico

24. Janssen Research and Development Spring House, Spring House, PA, USA

25. Janssen Pharmaceutica NV, Beerse, Belgic

26. Janssen Scientific Affairs LLC, Buenos Aires, Argentina

27. Medicine Birmingham, Department of Medicine, Division of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham, Birmingham, AL, USA

28. Department of Medicine, Universidad Peruana Cayetano Heredia, School of Medicine, Lima, Perú

Abstract

Objectives To identify the predictive factors of first hospitalization and associated variables to the main causes of hospitalizations in lupus patients from a Latin American cohort. Methods The first hospitalization after entry into the cohort during these patients’ follow-up due to either lupus disease activity and/or infection was examined. Clinical and therapeutic variables were those occurring prior to the first hospitalization. Descriptive statistical tests, multivariable logistic, and Cox regression models were performed. Results 1341 individuals were included in this analysis; 1200 (89.5%) were women. Their median and interquartile range (IQR) age at diagnosis were 27 (20–37) years and their median and IQR follow up time were 27.5 (4.7–62.2) months. A total of 456 (34.0%) patients were hospitalized; 344 (75.4%), 85 (18.6%) and 27 (5.9%) for disease activity, infections, or both, respectively. The predictors of the first hospitalization regardless of its cause were: medium (HR 2.03(1.27–3.24); p = 0.0028) and low (HR 2.42(1.55–3.79); p < 0.0001) socioeconomic status, serosal (HR 1.32(1.07–1.62); p = 0.0074) and renal (HR 1.50(1.23–1.82); p < 0.0001) involvement. Antimalarial (AM) use (HR 0.61(0.50–0.74); p < 0.0001) and achieving remission (HR 0.80(0.65–0.97); p = 0.0300) were negative predictors. Conclusions The first hospitalization was associated with worse socioeconomic status and serosal and renal involvement. Conversely, AM use and achieving remission were associated with a lower risk of hospitalizations.

Funder

Janssen Pharmaceutica

Publisher

SAGE Publications

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3